Nabeel Bardeesy Selected Research

Nabeel Bardeesy Research Topics

Disease

93	Neoplasms (Cancer) 04/2022 - 01/2002
22	Pancreatic Neoplasms (Pancreatic Cancer) 04/2022 - 06/2008
18	Adenocarcinoma 01/2022 - 06/2004
15	Cholangiocarcinoma 01/2022 - 04/2014
12	Carcinogenesis 11/2019 - 10/2003
11	Neoplasm Metastasis (Metastasis) 04/2022 - 04/2006
9	Lung Neoplasms (Lung Cancer) 11/2021 - 01/2008
7	Fibrosis (Cirrhosis) 01/2021 - 04/2014
6	Hypoxia (Hypoxemia) 01/2022 - 03/2008
5	Peutz-Jeghers Syndrome (Polyposis, Hamartomatous Intestinal) 01/2019 - 07/2004
4	Hepatocellular Carcinoma (Hepatoma) 01/2020 - 04/2014
3	Disease Progression 10/2021 - 03/2010
3	Inflammation (Inflammations) 11/2014 - 07/2011
3	Polyps 02/2014 - 07/2004
2	Carcinoma (Carcinomatosis) 01/2022 - 01/2008
2	Biliary Tract Neoplasms (Biliary Tract Cancer) 10/2021 - 01/2016
2	Liver Diseases (Liver Disease) 01/2021 - 04/2014
2	Non-alcoholic Fatty Liver Disease 01/2021 - 01/2019
2	Tuberous Sclerosis (Bourneville's Disease) 01/2019 - 07/2004
2	Circulating Neoplastic Cells 01/2019 - 09/2014
2	Liver Neoplasms (Liver Cancer) 01/2018 - 09/2014
2	Hypersensitivity (Allergy) 01/2016 - 08/2013
2	Mitochondrial Diseases (Mitochondrial Disease) 08/2015 - 12/2010
2	Liver Cirrhosis (Hepatic Cirrhosis) 08/2015 - 04/2014
2	Melanoma (Melanoma, Malignant) 01/2015 - 05/2005
2	Colonic Neoplasms (Colon Cancer) 03/2012 - 03/2006
1	Stomach Neoplasms (Stomach Cancer) 12/2021

Drug/Important Bio-Agent (IBA)

13	Proteins (Proteins, Gene)FDA Link 01/2019 - 03/2006
12	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2004
10	Biological ProductsIBA 04/2017 - 07/2004
9	Phosphotransferases (Kinase)IBA 10/2021 - 03/2004
8	Isocitrate Dehydrogenase (Isocitrate Dehydrogenase (NAD+))IBA 01/2022 - 01/2014
5	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 06/2004
5	Cyclin-Dependent Kinase Inhibitor p16IBA 07/2014 - 01/2002
5	Biomarkers (Surrogate Marker)IBA 04/2014 - 01/2009
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 08/2013 - 03/2004
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2022 - 01/2015
4	MicroRNAs (MicroRNA)IBA 01/2022 - 09/2011
4	ChromatinIBA 01/2022 - 08/2009
4	Adenosine Triphosphate (ATP)IBA 12/2021 - 07/2004
4	Pharmaceutical PreparationsIBA 01/2021 - 09/2012
4	AMP-Activated Protein KinasesIBA 01/2019 - 03/2004
4	alpha-hydroxyglutarateIBA 09/2014 - 01/2014
3	Transcription Factors (Transcription Factor)IBA 01/2022 - 03/2008
3	infigratinibIBA 12/2021 - 01/2017
3	CollagenIBA 01/2020 - 09/2012
3	Mechanistic Target of Rapamycin Complex 1IBA 12/2016 - 05/2010
3	Messenger RNA (mRNA)IBA 10/2016 - 01/2010
3	ErbB Receptors (EGF Receptor)IBA 04/2014 - 05/2005
3	NucleotidesIBA 08/2013 - 01/2009
3	Peptides (Polypeptides)IBA 09/2012 - 01/2009
3	Transforming Growth Factor beta (TGF-beta)IBA 07/2009 - 11/2006
3	Adenosine Monophosphate (AMP)IBA 02/2008 - 03/2004
2	CytokinesIBA 04/2022 - 07/2011
2	InterferonsIBA 01/2022 - 01/2019
2	EnzymesIBA 01/2022 - 01/2014
2	LigandsIBA 12/2021 - 01/2010
2	futibatinibIBA 10/2021 - 01/2019
2	AlbuminsIBA 01/2021 - 12/2015
2	Contrast MediaIBA 01/2020 - 08/2010
2	folfirinoxIBA 01/2020 - 01/2018
2	Serine (L-Serine)FDA Link 11/2019 - 11/2016
2	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2019 - 01/2017
2	Antiviral Agents (Antivirals)IBA 01/2019 - 11/2014
2	Glutamine (L-Glutamine)FDA Link 01/2019 - 04/2013
2	trans-sodium crocetinate (crocetin)IBA 01/2019 - 07/2004
2	Polycomb Repressive Complex 2IBA 01/2017 - 01/2017
2	Sorafenib (BAY 43-9006)FDA Link 01/2017 - 05/2015
2	Sirolimus (Rapamycin)FDA Link 12/2016 - 03/2010
2	Mechanistic Target of Rapamycin Complex 2IBA 12/2016 - 01/2015
2	Cysteine (L-Cysteine)FDA Link 10/2016 - 01/2009
2	AntioxidantsIBA 10/2016 - 07/2011
2	Reactive Oxygen Species (Oxygen Radicals)IBA 10/2016 - 07/2015
2	Glucose (Dextrose)FDA LinkGeneric 08/2015 - 10/2009
2	Carbon Tetrachloride (Tetrachloromethane)IBA 08/2015 - 04/2014
2	Oxygen (Dioxygen)IBA 06/2015 - 08/2010
2	Small Interfering RNA (siRNA)IBA 03/2015 - 03/2006
2	Hyaluronic Acid (Hyaluronan)IBA 07/2014 - 09/2012
2	Epidermal Growth Factor (EGF)IBA 04/2014 - 05/2005
2	Insulin (Novolin)FDA Link 03/2014 - 04/2009
2	Complementary DNA (cDNA)IBA 01/2014 - 06/2004
2	CateninsIBA 01/2013 - 03/2012
2	Metformin (Glucophage)FDA LinkGeneric 05/2010 - 12/2005
2	MTOR InhibitorsIBA 03/2010 - 07/2004
2	ProteomeIBA 01/2009 - 06/2008
1	Drug CombinationsIBA 01/2022
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022
1	Glycogen Synthase (Synthase I)IBA 01/2022
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 12/2021
1	3' Untranslated Regions (3' UTR)IBA 11/2021
1	ivosidenibIBA 06/2021
1	Histamine Receptors (Histamine Receptor)IBA 01/2021
1	Nizatidine (Axid)FDA LinkGeneric 01/2021
1	Collagen Type I (Type I Collagen)IBA 01/2020
1	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 01/2020

Therapy/Procedure

26	Therapeutics 01/2022 - 03/2004
6	Drug Therapy (Chemotherapy) 01/2022 - 04/2010
3	Chemoprevention 01/2021 - 01/2014
3	Immunotherapy 01/2016 - 09/2012
2	Ligation 04/2014 - 01/2009